Abstract
Our objective was to assess the utility of PET-CT in five pediatric patients with Langerhans cell histiocytosis (LCH) who underwent PET-CT imaging for clinical staging and determination of lesion activity at various stages of treatment and follow-up. PET-CT combines the anatomic detail of CT and the physiologic activity of 18F-FDG imaging. We conclude that PET-CT information is clinically useful to evaluate disease activity and response to therapy and provides information that cannot be obtained from technetium 99m methylene diphosphonate bone scans or radiographs.
Similar content being viewed by others
References
Azouz EM, Saigal G, Rodriguez MM et al (2005) Langerhans cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 35:103–115
Jubran RF, Marachelian A, Dorey F et al (2005) Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 45:37–42
Binkovitz LA, Olshefski RS, Adler BH (2003) Coincidence FDG-PET in the evaluation of Langerhans’ cell histiocytosis: preliminary findings. Pediatr Radiol 33:598–602
Kellenberger CJ, Epelman M, Miller SF et al (2004) Fast STIR whole-body MR imaging in children. Radiographics 24:1317–1330
Minkov M, Grois N, Heitger A et al (2002) Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 39:581–585
Acknowledgements
This work was supported in part by grants P30 CA-21765 and P01 CA-20180 from the National Institutes of Health, a Center of Excellence grant from the state of Tennessee and the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaste, S.C., Rodriguez-Galindo, C., McCarville, M.E. et al. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 37, 615–622 (2007). https://doi.org/10.1007/s00247-007-0467-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-007-0467-4